Create a free account
Join Calaméo to publish and share documents with the world!
Rate and comment your favorite publications, download documents and share your readings with your friends.
Trials Show Promise of Human Virus to Treat Head and Neck Cancer Patients
3 pages
Published by
Star One Public Relations
PRESS RELEASE
Trials Show Promise of Human Virus to Treat Head and Neck
Cancer Patients
Cancers shrank for about one third of the patients who could be evaluated, and
disease stabilised for a further third.
For one patient, all signs of...
[More]
PRESS RELEASE
Trials Show Promise of Human Virus to Treat Head and Neck
Cancer Patients
Cancers shrank for about one third of the patients who could be evaluated, and
disease stabilised for a further third.
For one patient, all signs of their cancer
disappeared.
Leeds, UK - April 3, 2012 -- A naturally-occurring harmless human virus may be able to
boost the effects of two standard chemotherapy drugs in some cancer patients,
according to early stage trial data published today in Clinical Cancer Research.
RT3D, trade name Reolysin, is a new drug developed by Oncolytics Biotech Inc with
preclinical and clinical studies conducted at The Institute of Cancer Research (ICR) and
The Royal Marsden Hospital.
It is based on a virus (reovirus type 3 Dearing) that is
found in almost all adults’ respiratory and gastrointestinal tracts without causing any
symptoms.
RT3D has the ability to grow in and kill
certain types of cancer cells, but does not
grow in normal cells.
Previous trials injectin
[Less]
Tags
advanced,
cancer,
cancers,
chemotherapy,
clinical,
found,
head,
hospital,
marsden,
neck,
patients,
phase,
research,
royal,
study,
trial,
virus
